Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Glyburide measurement (procedure) |
Component |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Poisoning by glibenclamide |
Causative agent (attribute) |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental poisoning by glibenclamide |
Causative agent (attribute) |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Intentional poisoning by glibenclamide |
Causative agent (attribute) |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Poisoning caused by glibenclamide of undetermined intent |
Causative agent (attribute) |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glibenclamide adverse reaction |
Causative agent (attribute) |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to glibenclamide (finding) |
Causative agent (attribute) |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Overdose of glibenclamide |
Causative agent (attribute) |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental overdose by glibenclamide (disorder) |
Causative agent (attribute) |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional overdose by glibenclamide |
Causative agent (attribute) |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose de glibenclamide d'intention indéterminée |
Causative agent (attribute) |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glibenclamide 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glibenclamide 5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely glibenclamide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely glibenclamide 5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing glibenclamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glibenclamide micronized 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glibenclamide micronised 4.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely glibenclamide 6.3 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glibenclamide micronised 6 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glibenclamide micronised 3 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glibenclamide 1.25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing glibenclamide and metformin hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glibenclamide micronized (substance) |
Is a |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to glibenclamide (finding) |
Causative agent (attribute) |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glibenclamide 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glibenclamide 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glibenclamide 5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glibenclamide 5mg tablet |
Has basis of strength substance (attribute) |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glibenclamide 1.25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glibenclamide 1.25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glibenclamide 6.3 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glibenclamide 6.3 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glibenclamide 5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glibenclamide 5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glibenclamide 5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glibenclamide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glibenclamide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glibenclamide micronized (substance) |
Is modification of (attribute) |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely glibenclamide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glibenclamide 5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glibenclamide 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glibenclamide 5mg tablet |
Has precise active ingredient |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glibenclamide 1.25 mg oral tablet |
Has precise active ingredient |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glibenclamide 6.3 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing glibenclamide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing glibenclamide and metformin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glibenclamide- and metformin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glibenclamide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only glibenclamide and metformin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only glibenclamide and metformin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only glibenclamide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glibenclamide 5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glibenclamide 3.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glibenclamide 3.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glibenclamide 1.75 mg oral tablet |
Has precise active ingredient |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glibenclamide 1.75 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Glibenclamid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |